Search
Filter by Topic
- Reproduction (9) Apply Reproduction filter
- Disorders (6) Apply Disorders filter
- People (6) Apply People filter
- Experiments (4) Apply Experiments filter
- Legal (2) Apply Legal filter
- Organizations (2) Apply Organizations filter
- Outreach (2) Apply Outreach filter
- Publications (2) Apply Publications filter
- Technologies (2) Apply Technologies filter
- DNA (1) Apply DNA filter
- Ethics (1) Apply Ethics filter
- Processes (1) Apply Processes filter
- Reproductive Health Arizona (1) Apply Reproductive Health Arizona filter
- Theories (1) Apply Theories filter
Filter by Format
Pages
Franklin William Stahl (1929– )
Franklin William Stahl studied DNA replication, bacteriophages, and genetic recombination in the US during the mid-twentieth and early twenty-first centuries. With his colleague Matthew Meselson, Stahl performed an experiment called the Meselson-Stahl experiment, which provided evidence for a process called semi-conservative DNA replication. Semi-conservative replication is a process in which each strand of a parental DNA double helix serves as a template for newly replicated daughter strands, so that one parental strand is conserved in every daughter double helix.
Format: Articles
Subject: People
The Informed Consent Project
In 2013, Cynthia Daniels and a team of researchers at Rutgers University in New Brunswick, New Jersey, founded the Informed Consent Project. Daniels and the researchers assessed the medical accuracy of information within state-authored informational materials for abortion. States give those materials to women who want an abortion, but using their research, the Informed Consent Project found some information from those materials to be inaccurate, misleading, and coercive.
Format: Articles
Subject: Organizations
World Health Organization Guidelines (Option A, B, and B+) for Antiretroviral Drugs to Treat Pregnant Women and Prevent HIV Infection in Infants
To address the international Human Immunodeficiency Virus epidemic, the World Health Organization, or WHO, developed three drug treatment regimens between 2010 and 2012 specifically for HIV-positive pregnant women and their infants. WHO developed the regimens, calling them Option A, Option B, and Option B+, to reduce or prevent mother-to-child, abbreviated MTC, transmission of HIV. Each option comprises of different types and schedules of antiretroviral medications. As of 2018, WHO reported that in Africa alone about 1,200,000 pregnant women were living with untreated HIV.
Format: Articles
Subject: Reproduction, Processes, Disorders